Navigation Links
Vantia Therapeutics Appoints Rachel Morten as Head of Regulatory Affairs
Date:4/21/2009

that of nocturia which may result from other conditions such as overactive bladder.

About VA111913 and dysmenorrhoea:

VA111913 is an oral small molecule drug candidate in Phase I clinical development for prevention and treatment of dysmenorrhoea, a condition characterized by abnormal contractions of the uterus during menstruation causing severe pain. VA111913 acts by blocking vasopressin 1a receptors in smooth muscle in the uterus wall, which in response to elevated vasopressin levels leads to dysmenorrhoea. VA111913 has demonstrated in preclinical trials it can normalise smooth muscle contraction thereby offering the potential for it to be the first licensed drug that directly targets the cause of this condition in the uterus.

A Phase I trial with VA111913 is underway and expected to report during H1 2009, with Phase II proof of concept studies expected to start in H2 2009, involving up to 150 patients and completing in H2 2010.

Dysmenorrhoea affects a large number of women for whom there are currently no targeted therapies; treatments that are in common use however include over-the-counter painkillers (e.g. naproxen or ibuprofen) or oral contraceptives used 'off-label'. It is estimated that the market opportunity for a targeted drug for the prophylaxis and treatment of dysmenorrhoea is approximately US$1 billion per year.

    Contact details:


    Vantia Therapeutics

    Dr Jim Phillips, CEO              +44(0)238-076-3433
    ir@vantiatherapeutics.com         +44(0)7515-397176


    Citigate Dewe Rogerson
    Chris Gardner / Mark Swallow / Helena Galilee
    +44(0)207-638-9571
    chris.gardner@citigatedr.co.uk / mark.swallow@citigatedr.co.uk /
    helena.galilee@citigatedr.c
'/>"/>

SOURCE Vantia Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
3. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
4. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
5. Amsterdam Molecular Therapeutics to Release H1 2007 Results on August 29, 2007
6. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
7. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
8. Cell Therapeutics, Inc. Takes Corrective Actions in Response to Nasdaq Determination
9. Amsterdam Molecular Therapeutics Reports Half Year Results 2007
10. Nektar Therapeutics Appoints Lutz Lingnau as New Board Member
11. Anesiva Grants Specific-Use License of Its Needle-Free Drug Delivery Technology to Particle Therapeutics for Diabetes Drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... April 1, 2015 /PRNewswire/ - Portage Biotech Inc. ... is pleased to announce that Biohaven Pharmaceutical Holding ... has entered into an agreement with inVentiv Health ... trial with their lead compound (BHV-0223). ... development of clinical stage neuroscience compounds targeting the ...
(Date:4/1/2015)... LAUDERDALE, Fla. , April 1, 2015  Among ... at all about oral cancer (68 percent) and only ... their last dental check-up, according to findings from a ... ("Vigilant"), a leading innovator and developer of solutions ... cancer. The online survey polled 1,050 U.S. ...
(Date:4/1/2015)... NEW YORK , April 1, 2015 /PRNewswire/ ... company advancing protein biologic therapies and oncology supportive ... Company,s 2014 achievements and a strategic update for ... the Company has made in the areas of ... MuGard programs, the FDA clearance of the ProctiGard ...
(Date:4/1/2015)... and LONDON , April 1, ... reports and solutions, MarketResearch.com is pleased to highlight a report ... year of market growth and opportunity for the stem cell ... or cord blood bank, competing in the stem cell marketplace ... industry trends, and act on market changes before the competition. ...
Breaking Biology Technology:Portage's Biohaven Announces Agreement with inVentiv Health 2Portage's Biohaven Announces Agreement with inVentiv Health 3National Oral Cancer Awareness Survey Reveals Greater Need for Education and Screening Tools for Oral Cancer Among U.S. Adults 2National Oral Cancer Awareness Survey Reveals Greater Need for Education and Screening Tools for Oral Cancer Among U.S. Adults 3National Oral Cancer Awareness Survey Reveals Greater Need for Education and Screening Tools for Oral Cancer Among U.S. Adults 4PlasmaTech Biopharmaceuticals Provides Strategic Update for 2015 and Review of 2014 Acheivements 2PlasmaTech Biopharmaceuticals Provides Strategic Update for 2015 and Review of 2014 Acheivements 3PlasmaTech Biopharmaceuticals Provides Strategic Update for 2015 and Review of 2014 Acheivements 4PlasmaTech Biopharmaceuticals Provides Strategic Update for 2015 and Review of 2014 Acheivements 5PlasmaTech Biopharmaceuticals Provides Strategic Update for 2015 and Review of 2014 Acheivements 6MarketResearch.com: "Blockbuster" Year for Stem Cells Creates Market Opportunities, Says BioInformant Worldwide Report 2MarketResearch.com: "Blockbuster" Year for Stem Cells Creates Market Opportunities, Says BioInformant Worldwide Report 3MarketResearch.com: "Blockbuster" Year for Stem Cells Creates Market Opportunities, Says BioInformant Worldwide Report 4
... Technologies, Inc. (NYSE Amex: PTN ) will host ... 11:00 a.m. Eastern Time to discuss its quarter ended December ... development.   Schedule for the Financial Results ... 2011 Conference Call-Live Domestic Dial-In Number , International Dial-In ...
... of Pittsburgh have been awarded funding for two projects that ... injuries to test if it is possible for them to ... prosthetic limb, with their thoughts. The projects build upon ... temporarily placed on their brains and were able to move ...
... to sharpen images of celestial bodies can now help scientists ... of a mouse. Eric Betzig, a group leader at the ... his team,s latest work using adaptive optics for biology at ... of Science in Washington, D.C. during a press conference on ...
Cached Biology Technology:New Pitt projects will test brain computer interfaces for people with spinal cord injury 2Improving microscopy by following the astronomers' guide star 2Improving microscopy by following the astronomers' guide star 3Improving microscopy by following the astronomers' guide star 4
(Date:3/26/2015)... , March 26, 2015 ... family, social, recreation and athletic club, today announced it ... to allow freedom of movement for members and staff, ... "Following a comprehensive process, we selected FST,s IMID Access ... and convenience for our members and staff, in addition ...
(Date:3/24/2015)... 2015   NexID Biometrics LLC, whose spoof-mitigation ... today announced the beginning of shipments of version 2.0 ... The company, based in Potsdam, N.Y. ... Expo, which began here today at the Walter E. ... of its SDK boosts the accuracy rate range to ...
(Date:3/23/2015)... 23, 2015   HOYOS Labs , a leading ... announced that the Company will demonstrate multiple biometrics-based technologies ... consumers at Connect:ID on March 23 through 25, 2015, ... will highlight the IEEE Biometric Open Protocol Standard; free ... enterprise access control system. BOPS was invented by HOYOS ...
Breaking Biology News(10 mins):Granite Club First Private Club in North America to Implement FST Biometrics Secure Access Solution, as Part of Multi-million Dollar Expansion 2NexID Begins Shipments Of Version 2.0 Fake-Finger-Detection Solution 2HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 2HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 3
... Wiley & Sons, Inc., a global provider of content-enabled ... research; professional development; and education, in 2013. The titles ... or self-publication, and 14 new titles, of which eight ... with over 30 societies and associations. Included in ...
... Evolutionary Bioinformatics Laboratory at the University of Illinois in ... to probe the world of proteins for answers to ... are formed from chains of amino acids and fold ... crop sciences professor Gustavo Caetano-Anolls, very little is known ...
... AMHERST, Mass. For hundreds of years, naturalists ... an organism,s visible differences. But now, new genetic ... little, to no visible differences. In a ... Massachusetts Amherst and the American Museum of Natural ...
Cached Biology News:66 titles join Wiley's journal portfolio in 2013 2Untangling life's origins 2Untangling life's origins 3Researchers develop tools for discovering new species 2Researchers develop tools for discovering new species 3
Total Proteins from over 50 different human Alzheimer, Diabetic, Liver Cirrhosis, and Lupus diseased tissues are available....
... The T2-02 diaphragm pump features T Squareds ... achieves remarkable performance and efficiency. With the ... range, T2-02 is ideal for use in ... ultra-compact size, long life, and high efficiency. ...
...
Alkaline Phosphatase (E. coli C75), 100 units. Removes 5'-phosphates from DNA. Category: Nucleotides & Enzymes & Biochemicals, Modifying Enzymes, Alkaline Phosphatases....
Biology Products: